Submission Excellence: Contributing Toward a Robust Strategy
Most life sciences organizations find it difficult to streamline their Regulatory submissions process due to frequent changes in the submission guidelines. According to a recent analysis conducted by the United States Food and Drug Administration (USFDA), 32% of submissions with study data had critical data conformance issues. The process necessitates an extensive understanding of collaboration among internal and external stakeholders.